These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 15690338

  • 1. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H.
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindán J.
    Cancer; 2001 Feb 25; 93(1):68-72. PubMed ID: 11241268
    [Abstract] [Full Text] [Related]

  • 3. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY, Li GD, Liu WP, Xie B, Jiang YH.
    Diagn Cytopathol; 2011 Dec 25; 39(12):900-8. PubMed ID: 20836004
    [Abstract] [Full Text] [Related]

  • 4. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH, Kim GE, Choi YD, Lee JS, Lee JH, Nam JH, Choi C.
    Diagn Cytopathol; 2009 Apr 25; 37(4):258-61. PubMed ID: 19217030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E, Langfort R, Roszkowski-Sliz K.
    Pneumonol Alergol Pol; 2007 Apr 25; 75(1):57-69. PubMed ID: 17541913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells.
    Ruitenbeek T, Gouw AS, Poppema S.
    Arch Pathol Lab Med; 1994 Mar 25; 118(3):265-9. PubMed ID: 8135629
    [Abstract] [Full Text] [Related]

  • 13. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
    Marsan C, Gaulier A, Sabatier P, Garcia R.
    Arch Anat Cytol Pathol; 1993 Mar 25; 41(5-6):223-8. PubMed ID: 8135583
    [Abstract] [Full Text] [Related]

  • 14. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE, Novelli L, Boddi V, Paglierani M, Dini S.
    Hum Pathol; 2001 May 25; 32(5):529-36. PubMed ID: 11381372
    [Abstract] [Full Text] [Related]

  • 15. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW, Koivurinne K.
    Cytopathology; 2008 Aug 25; 19(4):218-23. PubMed ID: 17916095
    [Abstract] [Full Text] [Related]

  • 16. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV, Nesland JM, Davidson B.
    Am J Surg Pathol; 2006 Jul 25; 30(7):878-82. PubMed ID: 16819331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
    Kimura F, Kawamura J, Watanabe J, Kamoshida S, Kawai K, Okayasu I, Kuwao S.
    Diagn Cytopathol; 2010 Mar 25; 38(3):161-7. PubMed ID: 19821496
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
    Hyun TS, Barnes M, Tabatabai ZL.
    Acta Cytol; 2012 Mar 25; 56(5):527-32. PubMed ID: 23075894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.